Explore
Validate
Learn
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- ELISA [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN393508 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Receptor (G Protein-Coupled) Activity Modifying Protein 1 (RAMP1) (AA 27-118) antibody
- Antibody type
- Monoclonal
- Description
- This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
- Reactivity
- Human
- Host
- Mouse
- Epitope
- AA 27-118
- Isotype
- IgG
- Antibody clone number
- 1F1
- Vial size
- 100 μg
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Submitted references Haplotype-based case-control study of receptor (calcitonin) activity-modifying protein-1 gene in cerebral infarction.
Receptor activity-modifying protein 1 increases baroreflex sensitivity and attenuates Angiotensin-induced hypertension.
Mapping the CGRP receptor ligand binding domain: tryptophan-84 of RAMP1 is critical for agonist and antagonist binding.
Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
Crystal structure of the human receptor activity-modifying protein 1 extracellular domain.
Nakazato T, Nakayama T, Naganuma T, Sato N, Fu Z, Wang Z, Soma M, Sugama K, Hinohara S, Doba N
Journal of human hypertension 2010 May;24(5):351-8
Journal of human hypertension 2010 May;24(5):351-8
Receptor activity-modifying protein 1 increases baroreflex sensitivity and attenuates Angiotensin-induced hypertension.
Sabharwal R, Zhang Z, Lu Y, Abboud FM, Russo AF, Chapleau MW
Hypertension (Dallas, Tex. : 1979) 2010 Mar;55(3):627-35
Hypertension (Dallas, Tex. : 1979) 2010 Mar;55(3):627-35
Mapping the CGRP receptor ligand binding domain: tryptophan-84 of RAMP1 is critical for agonist and antagonist binding.
Moore EL, Gingell JJ, Kane SA, Hay DL, Salvatore CA
Biochemical and biophysical research communications 2010 Mar 26;394(1):141-5
Biochemical and biophysical research communications 2010 Mar 26;394(1):141-5
Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
Qi T, Christopoulos G, Bailey RJ, Christopoulos A, Sexton PM, Hay DL
Molecular pharmacology 2008 Oct;74(4):1059-71
Molecular pharmacology 2008 Oct;74(4):1059-71
Crystal structure of the human receptor activity-modifying protein 1 extracellular domain.
Kusano S, Kukimoto-Niino M, Akasaka R, Toyama M, Terada T, Shirouzu M, Shindo T, Yokoyama S
Protein science : a publication of the Protein Society 2008 Nov;17(11):1907-14
Protein science : a publication of the Protein Society 2008 Nov;17(11):1907-14
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- ELISA
